Oxurion (Euronext Brussels: OXUR) is a Belgian holding company building a leading group of clinical research organizations (CROs) in Europe. By acquiring and integrating specialist CROs across the full clinical research value chain — from study design, regulatory affairs and clinical operations to data management, biostatistics, medical writing, pharmacovigilance, real-world evidence and market access — Oxurion creates an integrated, end-to-end platform, supporting drug and device development from early phases to post-approval, serving the pharmaceutical, biotechnology and medtech industries.